88 related articles for article (PubMed ID: 20943816)
1. Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo.
Bonzo JA; Patterson AD; Krausz KW; Gonzalez FJ
Mol Endocrinol; 2010 Dec; 24(12):2343-55. PubMed ID: 20943816
[TBL] [Abstract][Full Text] [Related]
2. Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.
Servitja JM; Pignatelli M; Maestro MA; Cardalda C; Boj SF; Lozano J; Blanco E; Lafuente A; McCarthy MI; Sumoy L; Guigó R; Ferrer J
Mol Cell Biol; 2009 Jun; 29(11):2945-59. PubMed ID: 19289501
[TBL] [Abstract][Full Text] [Related]
3. Effect of mutation at c.493T>C locus of transcription factor HNF1α gene on its protein level.
Shu-Jie L; Yi-Hua P; Jia-Hong L; Ai-Min J; Hong J; Yan C
Yi Chuan; 2024 Mar; 46(3):256-262. PubMed ID: 38632103
[TBL] [Abstract][Full Text] [Related]
4. HNF1α maintains pancreatic α and β cell functions in primary human islets.
Qian MF; Bevacqua RJ; Coykendall VM; Liu X; Zhao W; Chang CA; Gu X; Dai XQ; MacDonald PE; Kim SK
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37943614
[TBL] [Abstract][Full Text] [Related]
5. Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach.
P S; D TK; C GPD; R S; Zayed H
PLoS One; 2017; 12(4):e0174953. PubMed ID: 28410371
[TBL] [Abstract][Full Text] [Related]
6. Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A.
Cardenas-Diaz FL; Osorio-Quintero C; Diaz-Miranda MA; Kishore S; Leavens K; Jobaliya C; Stanescu D; Ortiz-Gonzalez X; Yoon C; Chen CS; Haliyur R; Brissova M; Powers AC; French DL; Gadue P
Cell Stem Cell; 2019 Aug; 25(2):273-289.e5. PubMed ID: 31374199
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.
Patterson AD; Bonzo JA; Li F; Krausz KW; Eichler GS; Aslam S; Tigno X; Weinstein JN; Hansen BC; Idle JR; Gonzalez FJ
J Biol Chem; 2011 Jun; 286(22):19511-22. PubMed ID: 21487016
[TBL] [Abstract][Full Text] [Related]
8. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.
Mathé EA; Patterson AD; Haznadar M; Manna SK; Krausz KW; Bowman ED; Shields PG; Idle JR; Smith PB; Anami K; Kazandjian DG; Hatzakis E; Gonzalez FJ; Harris CC
Cancer Res; 2014 Jun; 74(12):3259-70. PubMed ID: 24736543
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans.
Manna SK; Tanaka N; Krausz KW; Haznadar M; Xue X; Matsubara T; Bowman ED; Fearon ER; Harris CC; Shah YM; Gonzalez FJ
Gastroenterology; 2014 May; 146(5):1313-24. PubMed ID: 24440673
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics reveals aging-associated attenuation of noninvasive radiation biomarkers in mice: potential role of polyamine catabolism and incoherent DNA damage-repair.
Manna SK; Krausz KW; Bonzo JA; Idle JR; Gonzalez FJ
J Proteome Res; 2013 May; 12(5):2269-81. PubMed ID: 23586774
[TBL] [Abstract][Full Text] [Related]
12. Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats.
Johnson CH; Patterson AD; Krausz KW; Lanz C; Kang DW; Luecke H; Gonzalez FJ; Idle JR
Radiat Res; 2011 Apr; 175(4):473-84. PubMed ID: 21309707
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine Pathway in Diabetes Mellitus-Novel Pharmacological Target?
Kozieł K; Urbanska EM
Cells; 2023 Jan; 12(3):. PubMed ID: 36766803
[TBL] [Abstract][Full Text] [Related]
14. Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model.
Niborski LL; Paces-Fessy M; Ricci P; Bourgeois A; Magalhães P; Kuzma-Kuzniarska M; Lesaulnier C; Reczko M; Declercq E; Zürbig P; Doucet A; Umbhauer M; Cereghini S
Dis Model Mech; 2021 May; 14(5):. PubMed ID: 33737325
[TBL] [Abstract][Full Text] [Related]
15. The Roles of Long Noncoding RNAs HNF1α-AS1 and HNF4α-AS1 in Drug Metabolism and Human Diseases.
Chen L; Bao Y; Jiang S; Zhong XB
Noncoding RNA; 2020 Jun; 6(2):. PubMed ID: 32599764
[TBL] [Abstract][Full Text] [Related]
16. Salusin-β as a powerful endogenous antidipsogenic neuropeptide.
Suzuki-Kemuriyama N; Nakano-Tateno T; Tani Y; Hirata Y; Shichiri M
Sci Rep; 2016 Feb; 6():20988. PubMed ID: 26869388
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic analyses for atherosclerosis, diabetes, and obesity.
Du F; Virtue A; Wang H; Yang XF
Biomark Res; 2013 Apr; 1(1):17. PubMed ID: 24252331
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
Gloyn AL; Faber JH; Malmodin D; Thanabalasingham G; Lam F; Ueland PM; McCarthy MI; Owen KR; Baunsgaard D
PLoS One; 2012; 7(7):e40962. PubMed ID: 22859960
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.
Li F; Patterson AD; Krausz KW; Tanaka N; Gonzalez FJ
J Lipid Res; 2012 Aug; 53(8):1625-35. PubMed ID: 22665165
[TBL] [Abstract][Full Text] [Related]
20. Challenges and opportunities of metabolomics.
Johnson CH; Gonzalez FJ
J Cell Physiol; 2012 Aug; 227(8):2975-81. PubMed ID: 22034100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
